Kim Chloe, Searson Peter C
Department of Materials Science and Engineering, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA.
Nanoscale. 2015 Nov 14;7(42):17820-6. doi: 10.1039/c5nr05608j. Epub 2015 Oct 12.
Current diagnostic methods for traumatic brain injury (TBI), which accounts for 15% of all emergency room visits, are limited to neuroimaging modalities. The challenges of accurate diagnosis and monitoring of TBI have created the need for a simple and sensitive blood test to detect brain-specific biomarkers. Here we report on an assay for detection of S100B, a putative biomarker for TBI, using antibody-conjugated magnetic beads for capture of the protein, and antibody-conjugated quantum dots for optical detection. From Western Blot, we show efficient antigen capture and concentration by the magnetic beads. Using magnetic bead capture and quantum dot detection in serum samples, we show a wide detection range and detection limit below the clinical cut-off level.
创伤性脑损伤(TBI)占所有急诊室就诊病例的15%,目前其诊断方法仅限于神经成像模式。准确诊断和监测TBI面临的挑战使得需要一种简单且灵敏的血液检测方法来检测脑特异性生物标志物。在此,我们报告一种检测S100B的分析方法,S100B是一种假定的TBI生物标志物,该方法使用抗体偶联磁珠捕获蛋白质,并使用抗体偶联量子点进行光学检测。从蛋白质印迹法结果来看,我们展示了磁珠对抗原的高效捕获和浓缩。在血清样本中使用磁珠捕获和量子点检测,我们展示了较宽的检测范围以及低于临床临界值的检测限。